Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia

GlobeNewswire May 16, 2018

Aphria signs exclusive agreement with Colombia-based Colcanna SAS to supply medical cannabis in Colombia

Canada NewsWire May 16, 2018

Growing Cannabis Sales Expected to Have Strong Economic Benefits

PR Newswire May 10, 2018

Legal and Medical Cannabis Markets are Outpacing Previous Estimates

PR Newswire May 3, 2018

Aphria Appoints Chief Commercial Officer and Chief Legal Officer Adding Depth to Leadership Team and Implements New Governance Initiatives

Canada NewsWire April 25, 2018

Aphria completes first medical cannabis shipment to Australia-based partner Althea

Canada NewsWire April 24, 2018

Broken Coast Cannabis Nearly Doubles Production Capacity with Health Canada Approval of Phase III Expansion

Canada NewsWire April 23, 2018

Pot Stocks, ETFs And Top News From The Cannabis Industry This Week

Benzinga.com  April 20, 2018

Legal Cannabis Market Sales are Projected to Increase at a Strong Rate

PR Newswire April 20, 2018

Scythian Announces ABP S.A.’s First Purchase Order with Aphria Inc.

GlobeNewswire April 18, 2018

Aphria Launches Solei, its First Adult-Use Brand, Designed for the Modern Cannabis Consumer

Canada NewsWire April 17, 2018

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry

Benzinga.com  April 16, 2018

Aphria Inc. - Revenue Growth and Sub $1.00 Cash Cost per Gram Metric Highlight Quarter

Canada NewsWire April 16, 2018

Aphria finalizes three-year supply agreement with the SAQ to provide up to 12,000 kg of cannabis annually to Quebec market

Canada NewsWire April 11, 2018

Aphria to Announce Third Quarter Results on April 16, 2018

Canada NewsWire April 10, 2018

Aphria provides update on Part III expansion operations

Canada NewsWire April 5, 2018

Pot Stocks, ETFs And Top News From The Cannabis Industry

Benzinga.com  April 2, 2018

Aphria launches Aphria International and provides updates on worldwide operations

Canada NewsWire March 27, 2018

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

Benzinga.com  March 23, 2018

Aphria and Nuuvera Announce Closing Of Arrangement

Canada NewsWire March 23, 2018